ArticleKidney medicine2026
Estimating Short-Term and Long-Term Survival for Patients With Kidney Failure Using a Mixture Survival Model.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The prediction of all-cause mortality in end-stage kidney disease patients using social determinants of health: A machine learning framework.Informatics in medicine unlocked · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Rationale & Objective: Traditional survival models assume all patients receiving kidney replacement therapy (KRT) may be grouped into one population, overlooking long-term survivors, particularly successful transplant recipients, and may fail to appreciate the disparities in minority populations. On the other hand, a mixture survival model allows for the estimation of hazard and odds ratios of all-cause mortality in patients with kidney failure undergoing either dialysis or transplantation. Study Design: This retrospective cohort study analyzed survival outcomes using a proportional hazards mixture survival model, comparing results to a traditional Cox proportional hazards model with time-varying modality of treatment. Setting & Participants: Data from the United States Renal Data System included 2,228,693 patients initiating KRT between 2000 and 2020. Predictors: Key predictors included demographics, comorbid conditions, socioeconomic status, geographic location, and rurality. Outcomes: The primary outcome was all-cause mortality. The mixture survival model distinguishes between patients' characteristics associated with long-term survival (ie, primarily those with successful transplants) and short-term survival (ie, those at a greater risk of mortality over time, such as patients treated with dialysis). Analytical Approach: Both a Cox proportional hazards model and a proportional hazards mixture survival model were applied to all patients. Results: Findings from both models were largely consistent, but the mixture survival model revealed new insights into racial disparities. In the Cox model, American Indian individuals had an adjusted hazard ratio of 0.63 compared with White individuals (95% CI. 0.62-0.63) and 0.74 for Black individuals compared with White (95% CI, 0.74-0.74). The mixture model confirmed these trends but also showed that American Indian individuals were 1.59 times more likely to not have a long-term survival than White individuals (95% CI, 1.415-1.797) and Black individuals were 1.35 times more likely to not be in the long-term surviving group than White individuals (95% CI, 1.310-1.397). Additional disparities were observed by socioeconomic and geographic factors. Limitations: Data collected at the beginning of dialysis may not fully capture patients' health trajectories. Conclusions: The mixture survival model provides a more comprehensive understanding of mortality disparities for patients with kidney failure receiving KRT by distinguishing between short-term and long-term survivability. The findings highlight the need for targeted interventions to improve long-term outcomes for minority patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.